| Lastest Insider Transactions Of REPLIGEN CORP ( RGEN ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-03-11 | Sell | 3,517 | 193.73 | 681,348 | 2024-03-12 20:24:20 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-03-11 | Option Exercise | 1,271 | 86.10 | 109,433 | 2024-03-12 20:24:20 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Officer | 2024-03-08 | Sell | 16,707 | 197.44 | 3,298,632 | 2024-03-11 19:43:36 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Officer | 2024-03-08 | Option Exercise | 1 | 16.55 | 17 | 2024-03-11 19:43:36 |
| RGEN | REPLIGEN CORP | DAWES KAREN A | Directior | 2024-02-27 | Sell | 1,000 | 193.35 | 193,350 | 2024-02-28 21:56:23 |
| RGEN | REPLIGEN CORP | DAWES KAREN A | Directior | 2024-02-27 | Option Exercise | 4,626 | 42.07 | 194,616 | 2024-02-28 21:56:23 |
| RGEN | REPLIGEN CORP | Bylund James | Chief Operating Officer | 2024-02-23 | Sell | 4,373 | 198.08 | 866,204 | 2024-02-26 20:38:26 |
| RGEN | REPLIGEN CORP | Bylund James | Chief Operating Officer | 2024-02-23 | Option Exercise | 940 | 94.33 | 88,670 | 2024-02-26 20:38:26 |
| RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | 2023-11-10 | Sell | 3,788 | 147.13 | 557,328 | 2023-11-13 17:10:34 |
| RGEN | REPLIGEN CORP | DAWES KAREN A | Directior | 2023-08-29 | Sell | 850 | 171.38 | 145,673 | 2023-08-30 16:06:03 |
| RGEN | REPLIGEN CORP | DAWES KAREN A | Directior | 2023-08-29 | Option Exercise | 7,392 | 18.12 | 133,943 | 2023-08-30 16:06:03 |
| RGEN | REPLIGEN CORP | Madaus Martin D | Directior | 2023-03-24 | Buy | 1,500 | 158.84 | 238,260 | 2023-05-08 21:15:01 |
| RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Officer | 2023-02-16 | Sell | 5,647 | 200.00 | 1,129,400 | 2023-02-17 16:56:31 |
| RGEN | REPLIGEN CORP | EGLINTON MANNER CARRIE | Directior | 2022-03-16 | Buy | 625 | 175.02 | 109,388 | 2022-12-15 06:55:39 |
